STAT+: Vinod Khosla predicts AI doctors could be here sooner than you think
Sun Microsystems co-founder Vinod Khosla is famous for predictions that have helped usher in the…
Author: STAT
STAT+: What the Covid-19 pandemic can teach us about drug patents
Inventing treatments and vaccines is only part of the battle in an epidemic and pandemic,…
After early-stage breast cancer, interrupting endocrine therapy to become pregnant didn’t raise risk of recurrence
Women who’ve been treated for hormone-sensitive breast cancer often face five to 10 years of…
For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest
If you flip to the 1,031st page of the May 1998 edition of the Journal…
Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity
The Food and Drug Administration approves dozens of cancer drugs every year, but the vast…
Oft-prescribed beta blockers may not be wise for many heart patients
Beta blockers have long been widely prescribed for patients with heart issues, but two new…
DEA will delay telemedicine restrictions for buprenorphine, Adderall and other drugs
The Drug Enforcement Administration is holding off on making sweeping changes to the way certain…
FDA approves first RSV vaccine, a long-sought scientific achievement
The Food and Drug Administration on Wednesday licensed the first-ever vaccine for respiratory syncytial virus,…
STAT+: Pharmalittle: Lilly’s Alzheimer’s drug slowed cognitive decline; most EU countries back plan to push production of key drugs
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Immunogen ovarian cancer drug shown to extend patients’ lives
A drug approved in November as the first new treatment for advanced ovarian cancer in…
STAT+: In early glimpse at data, Akili’s video game shows positive results with adults with ADHD
Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment…
STAT+: Eli Lilly’s Alzheimer’s therapy slowed patients’ rate of cognitive decline, data show
A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive…
Opinion: Listen: Two medical residents debate their hospital’s unionization drive
In training to become a physician, medical residency can be a grueling period. Residents and…
RJ Reynolds is threatening to sue vape shops for selling flavored vapes
WASHINGTON – The tobacco giant RJ Reynolds is threatening to sue small vape shops if…
STAT+: Biden’s pick to lead NIH stares down an increasingly political litany of questions
WASHINGTON — President Biden’s presumed pick to lead the National Institutes of Health, Monica Bertagnolli,…
Opinion: The Global North can’t solve its health care worker shortage by stealing from the Global South
The U.S. is facing unprecedented health care labor shortages and related cost pressures. In the U.K., the…
.jpg)
STAT+: The CEO of 23andMe says people are willing to share health data — if ‘treated like adults’
When it comes to personal health information, many people are actually willing to share their…
STAT+: Disagreements and digs upend an otherwise bipartisan hearing on PBM reform
WASHINGTON — The first Senate health committee markup under Chairman Bernie Sanders (I-Vt.) and ranking…
Rise in suicide-related ED visits among youth raises larger questions around mental health care
Visits to the emergency department related to suicide among children and adults aged 6 to…
STAT+: Pharmalittle: Senate PBM reform bill delays effective date; Gilead and HHS square off in court over HIV patents
Good morning, everyone, and how are you today? Steely skies are hovering this morning over…
STAT+: What to know about the upcoming readout of Eli Lilly’s experimental Alzheimer’s therapy
Eli Lilly is nearing the readout from a pivotal study of its experimental treatment for…
Loneliness poses risks as deadly as smoking, surgeon general warns
WASHINGTON — Widespread loneliness in the U.S. poses health risks as deadly as smoking a dozen…
STAT+: Legal battle between Apple and Masimo over trade secrets ends in mistrial
A California jury was unable to reach a verdict in a messy, drawn-out legal battle…
Opinion: Long waits to see a doctor are a public health crisis
In 2004, the physician search firm Merritt Hawkins first issued their Survey of Physician Appointment…
STAT+: A battle between Gilead and the U.S. government over patents on HIV prevention pills goes to trial
After years of sparring, the federal government and Gilead Sciences will square off in a…
Opinion: Do masks work? Randomized controlled trials are the worst way to answer the question
Early in the Covid-19 pandemic, before we had vaccines and effective medical procedures, the only…
Report on medical access finds one-third of Black Americans live in ‘cardiology deserts’
Many Black Americans would have to travel across county lines just to find an open…
STAT+: Tobacco control groups oppose a bill targeting disposable vapes — because they worry RJ Reynolds is behind it
WASHINGTON — There’s a new bill in Congress meant to crack down on the cheap…
Study: Ingredient found in salad bowls and burger wrappers less safe than previously thought
A compostable salad bowl seems like an Earth-friendly way to enjoy a healthy lunch. But…
For Spanish-speaking Latinas, language gaps — real or perceived — tied to discrimination during labor
The research question that pursued Jessica Valdez, an OB-GYN resident physician at the University of…
Travere Therapeutics drug, approved for one rare and deadly kidney disease, fails in study of another
SAN DIEGO — Travere Therapeutics, a biotech focused on treating rare diseases, on Monday announced…
STAT+: Most of Canada’s public research universities get bad grades for ensuring access to drugs they discover
Despite significant public funding, most of the 15 largest public research universities in Canada failed…
.jpg)
Hospitals that denied emergency abortion broke the law, feds say
WASHINGTON (AP) — Two hospitals that refused to provide an emergency abortion to a pregnant woman who…
Expansive investigation into Stanford president’s past research will be ‘substantially complete’ by mid-July
An investigation by a special committee of Stanford’s board of trustees into alleged scientific misconduct…
Babies born to opioid users have shorter hospital stays with parental involvement: study
Babies born to opioid users had shorter hospital stays and needed less medication when their…
STAT+: Senators delay start date for possible PBM reforms
WASHINGTON — Pharmacy benefit managers may have gotten themselves a slight reprieve. Senators drafting reforms to…
STAT+: Carbon Health blasts a major insurer in rare public dispute over coverage
OAKLAND, Calif. — Primary care startup Carbon Health blasted health insurer Elevance on Monday for…
In a small new study, scientists working on an AI ‘brain decoder’ inch closer than ever to reading minds
Alexander Huth settled into an MRI machine in the Austin, Texas, neuroscience research building where…
STAT+: Pharmalittle: More biotechs are betting on obesity; Pfizer RSV vaccine faces hurdles in low-income countries
Good morning, everyone, and nice to see you again after a week-long respite in which…
Survey: Anti-LGBTQ legislation takes alarming mental-health toll on queer youth
Across the U.S., anti-LGBTQ legislation — and especially anti-trans legislation — is limiting queer youth’s…
STAT+: Astellas acquires Iveric Bio for $5.9B, entering competition to treat common cause of vision loss
Japanese drugmaker Astellas said late Sunday it would acquire eye drug developer Iveric Bio for…
STAT+: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’
Over glasses of Chablis at Fleming by Le Bilboquet in Manhattan, two longtime friends and…
Opinion: The apparent poisoning of schoolgirls is just one part of Iran’s health crisis
On the first day back to school in April, after time off to celebrate the…
STAT+: Beyond Wegovy and Ozempic: Biotechs vie for piece of red-hot weight loss market with novel strategies
This is part of a series about new obesity drugs that are transforming patients’ lives,…
STAT+: New mega-deal highlights Geisinger’s fall, and raises concerns about where Kaiser is going next
In 2009, when President Barack Obama was touring the country and ginning up support for…
STAT+: Bright Health looks to get out of health insurance entirely
Bright Health Group started as a health insurance company. But it will no longer be…
STAT+: Once bullish on digital health, Orexo hits a wall on reimbursement
After several quarters of promising to deliver concrete progress on key digital therapeutics projects, Swedish…
STAT Wunderkinds discuss high-impact research, resilience, and social justice
Elenoe “Crew” Smith used to faint at the sight of blood. Still, she knew from…
STAT+: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability
Hello and happy Friday, with STAT reporter Andrew Joseph here steering the ship in place…
STAT+: Covid-19 burnished pharma’s reputation among patient groups, but access to medicines is now an issue
In the wake of the Covid-19 pandemic, the pharmaceutical industry enjoyed something of an afterglow,…